{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:34:48Z","timestamp":1778038488368,"version":"3.51.4"},"reference-count":30,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ALF","award":["966204"],"award-info":[{"award-number":["966204"]}]},{"name":"ALF","award":["ALFGBG-942665"],"award-info":[{"award-number":["ALFGBG-942665"]}]},{"name":"ALF","award":["ALFGBG-977905"],"award-info":[{"award-number":["ALFGBG-977905"]}]},{"DOI":"10.13039\/501100003793","name":"Swedish Heart-Lung Foundation","doi-asserted-by":"crossref","award":["20210433"],"award-info":[{"award-number":["20210433"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish government"},{"name":"Nils Winberg Family\u2019s Foundation"},{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["VGFOUREG-969376"],"award-info":[{"award-number":["VGFOUREG-969376"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,6,28]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The optimal medical therapy after surgical aortic valve replacement (SAVR) for aortic stenosis remains unknown. Renin\u2013angiotensin system (RAS) inhibitors could potentially improve cardiac remodelling and clinical outcomes after SAVR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>All patients undergoing SAVR due to aortic stenosis in Sweden 2006\u20132020 and surviving 6 months after surgery were included. The primary outcome was major adverse cardiovascular events (MACEs; all-cause mortality, stroke or myocardial infarction). Secondary endpoints included the individual components of MACE and cardiovascular mortality. Time-updated adjusted Cox regression models were used to compare patients with and without RAS inhibitors. Subgroup analyses were performed, as well as a comparison between angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 11\u2009894 patients (mean age, 69.5 years, 40.4%\u2009women) were included. Median follow-up time was 5.4 (2.7\u20138.5) years. At baseline, 53.6% of patients were dispensed RAS inhibitors, this proportion remained stable during follow-up. RAS inhibition was associated with a lower risk of MACE (adjusted hazard ratio (aHR) 0.87 (95% CI 0.81 to 0.93), p&lt;0.001), mainly driven by a lower risk of all-cause death (aHR 0.79 (0.73 to 0.86), p&lt;0.001). The lower MACE risk was consistent in all subgroups except for those with mechanical prostheses (aHR 1.07 (0.84 to 1.37), p for interaction=0.040). Both treatment with ACE inhibitors (aHR 0.89 (95% CI 0.82 to 0.97)) and ARBs (0.87 (0.81 to 0.93)) were associated with lower risk of MACE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The results of this study suggest that medical therapy with an RAS inhibitor after SAVR is associated with a 13% lower risk of MACE and a 21% lower risk of all-cause death.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-322922","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T13:20:50Z","timestamp":1689600050000},"page":"202-208","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Renin\u2013angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-0777","authenticated-orcid":false,"given":"Andreas","family":"Martinsson","sequence":"first","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Goteborg, Sweden"},{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotta","family":"T\u00f6rngren","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden"},{"name":"Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne J","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden"},{"name":"Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Harvard Medical School, Boston, Massachusetts, USA"},{"name":"University of Turku, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma C","family":"Hansson","sequence":"additional","affiliation":[{"name":"Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Taha","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Goteborg, Sweden"},{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Jeppsson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, University of Gothenburg Sahlgrenska Academy, Goteborg, Sweden"},{"name":"Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"2025092004553547000_110.3.202.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab395"},{"key":"2025092004553547000_110.3.202.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923"},{"key":"2025092004553547000_110.3.202.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00201-X"},{"key":"2025092004553547000_110.3.202.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69208-8"},{"key":"2025092004553547000_110.3.202.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.894170"},{"key":"2025092004553547000_110.3.202.6","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.jacc.2021.09.861","article-title":"Life expectancy after surgical aortic valve replacement","volume":"78","author":"Martinsson","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2025092004553547000_110.3.202.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab375"},{"key":"2025092004553547000_110.3.202.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025092004553547000_110.3.202.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"2025092004553547000_110.3.202.10","doi-asserted-by":"publisher","DOI":"10.1177\/1753944716642677"},{"key":"2025092004553547000_110.3.202.11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.238550"},{"key":"2025092004553547000_110.3.202.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"2025092004553547000_110.3.202.13","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2018.18077","article-title":"Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement","volume":"320","author":"Inohara","year":"2018","journal-title":"JAMA"},{"key":"2025092004553547000_110.3.202.14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ehjcvp\/pvac034","article-title":"Associations between medical therapy after surgical aortic valve replacement for aortic stenosis and long-term mortality: a report from the SWEDEHEART registry","volume":"8","author":"Baranowska","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025092004553547000_110.3.202.15","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.198804"},{"key":"2025092004553547000_110.3.202.16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/icvts\/ivy030","article-title":"Validity of the Swedish cardiac surgery registry","volume":"27","author":"Vikholm","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2025092004553547000_110.3.202.17","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-016-0117-y"},{"key":"2025092004553547000_110.3.202.18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish National inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2025092004553547000_110.3.202.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025092004553547000_110.3.202.20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/eurheartj\/ehz714","article-title":"Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART Registry","volume":"41","author":"Bj\u00f6rklund","year":"2020","journal-title":"Eur Heart J"},{"key":"2025092004553547000_110.3.202.21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025092004553547000_110.3.202.22","doi-asserted-by":"publisher","DOI":"10.2307\/2290085"},{"key":"2025092004553547000_110.3.202.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2011.04.044"},{"key":"2025092004553547000_110.3.202.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.035"},{"key":"2025092004553547000_110.3.202.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.12.1388"},{"key":"2025092004553547000_110.3.202.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.04.028"},{"key":"2025092004553547000_110.3.202.27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016911","article-title":"Renin-angiotensin system blockade in aortic stenosis: implications before and after aortic valve replacement","volume":"9","author":"Goel","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025092004553547000_110.3.202.28","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1113\/JP273043","article-title":"Hypertension-induced remodelling: on the interaction of cardiac risk factors","volume":"595","author":"Tomek","year":"2017","journal-title":"J Physiol"},{"key":"2025092004553547000_110.3.202.29","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00287.2006"},{"key":"2025092004553547000_110.3.202.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.05.055"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-322922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:55:45Z","timestamp":1758369345000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-322922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,1,10]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/heartjnl-2023-322922"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-322922","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}